Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B C Frykholm

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
The Johns Hopkins Medical Journal|December 1, 1979
Pregnancy and porphyria cutanea tardaJ M Lamon, B C Frykholm
The Journal of Pediatrics|February 1, 1978
Tyrosinemia with aminolevulinic dehydratase deficiencyJ M Lamon, B C Frykholm, D P Tschudy
Archives of Neurology|November 1, 1977
Screening tests in acute porphyriaJ M Lamon, B C Frykholm, D P Tschudy
Journal of Medical Genetics|April 1, 1979
Family evaluations in acute intermittent porphyria using red cell uroporphyrinogen I synthetaseJ M Lamon, B C Frykholm, D P Tschudy
The Journal of Biological Chemistry|October 10, 1981
Inhibition of delta-aminolevulinic acid dehydrase by 4,6-dioxoheptanoic acidD P Tschudy, R A Hess, B C Frykholm
Blood|May 1, 1979
Hematin administration to an adult with lead intoxicationJ M Lamon, B C Frykholm, D P Tschudy
Lancet (London, England)|September 2, 1978
Prevention of acute porphyric attacks by intravenous haematinJ M Lamon, B C Frykholm, M Bennett, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1979
Danazol administration to females with menses-associated exacerbations of acute intermittent porphyriaJ M Lamon, B C Frykholm, W Herrera, et al.
Cancer Biochemistry Biophysics|January 1, 1983
Characteristics of hematin uptake in malignant, embryonic and normal cellsP S Ebert, B C Frykholm, R A Hess, et al.
Biochemical and Biophysical Research Communications|June 27, 1979
Succinylacetone, a potent inhibitor of heme biosynthesis: effect on cell growth, heme content and delta-aminolevulinic acid dehydratase activity of malignant murine erythroleukemia cellsP S Ebert, R A Hess, B C Frykholm, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
The Johns Hopkins Medical Journal|December 1, 1979
Pregnancy and porphyria cutanea tardaJ M Lamon, B C Frykholm
The Journal of Pediatrics|February 1, 1978
Tyrosinemia with aminolevulinic dehydratase deficiencyJ M Lamon, B C Frykholm, D P Tschudy
Archives of Neurology|November 1, 1977
Screening tests in acute porphyriaJ M Lamon, B C Frykholm, D P Tschudy
Journal of Medical Genetics|April 1, 1979
Family evaluations in acute intermittent porphyria using red cell uroporphyrinogen I synthetaseJ M Lamon, B C Frykholm, D P Tschudy
The Journal of Biological Chemistry|October 10, 1981
Inhibition of delta-aminolevulinic acid dehydrase by 4,6-dioxoheptanoic acidD P Tschudy, R A Hess, B C Frykholm
Blood|May 1, 1979
Hematin administration to an adult with lead intoxicationJ M Lamon, B C Frykholm, D P Tschudy
Lancet (London, England)|September 2, 1978
Prevention of acute porphyric attacks by intravenous haematinJ M Lamon, B C Frykholm, M Bennett, et al.
The Journal of Clinical Endocrinology and Metabolism|January 1, 1979
Danazol administration to females with menses-associated exacerbations of acute intermittent porphyriaJ M Lamon, B C Frykholm, W Herrera, et al.
Cancer Biochemistry Biophysics|January 1, 1983
Characteristics of hematin uptake in malignant, embryonic and normal cellsP S Ebert, B C Frykholm, R A Hess, et al.
Biochemical and Biophysical Research Communications|June 27, 1979
Succinylacetone, a potent inhibitor of heme biosynthesis: effect on cell growth, heme content and delta-aminolevulinic acid dehydratase activity of malignant murine erythroleukemia cellsP S Ebert, R A Hess, B C Frykholm, et al.
Pageof 2